Cargando…

Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine †

The suppression of viral loads and identification of selection signatures in non-human primates after challenge are indicators for effective human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) vaccines. To mimic the protective immunity elicited by attenuated SIV vaccines, we devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chu, Jiang, Chunlai, Gao, Nan, Zhang, Kaikai, Liu, Donglai, Wang, Wei, Cong, Zhe, Qin, Chuan, Ganusov, Vitaly V., Ferrari, Guido, LaBranche, Celia, Montefiori, David C., Kong, Wei, Yu, Xianghui, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490812/ https://www.ncbi.nlm.nih.gov/pubmed/28574482 http://dx.doi.org/10.3390/v9060135

Ejemplares similares

Immunological and Virological Mechanisms of Vaccine-Mediated Protection Against SIV and HIV
por: Roederer, Mario, et al.
Publicado: (2013)

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
por: Tuero, Iskra, et al.
Publicado: (2015)

Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection
por: Ganusov, Vitaly V, et al.
Publicado: (2006)

Simple Mathematical Models Do Not Accurately Predict Early SIV Dynamics
por: Noecker, Cecilia, et al.
Publicado: (2015)

Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques
por: Pahar, Bapi, et al.
Publicado: (2022)

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
por: Negri, Donatella, et al.
Publicado: (2016)

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4
por: Welles, Hugh C., et al.
Publicado: (2022)

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection
por: Pittala, Srivamshi, et al.
Publicado: (2019)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV(mac251) acquisition in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

The Immunological Impact of Adenovirus Early Genes on Vaccine-Induced Responses in Mice and Nonhuman Primates
por: Sangare, Kotou, et al.
Publicado: (2021)

Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal
por: Van Rompay, Koen K A, et al.
Publicado: (2012)

Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
por: Blasi, Maria, et al.
Publicado: (2020)

Virology and Immunology of Bats
por: Schountz, Tony
Publicado: (2013)

Acute infection by SIV: massive immunological damage
por: Roederer, Mario
Publicado: (2006)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

Engagement of monocytes, NK cells, and CD4(+) Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIV(mac251) vaginal acquisition
por: Gorini, Giacomo, et al.
Publicado: (2020)

Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
por: Blasi, Maria, et al.
Publicado: (2020)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques
por: Pahar, Bapi, et al.
Publicado: (2016)

CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses
por: Lewis, Phoebe E., et al.
Publicado: (2020)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
por: Jia, Bin, et al.
Publicado: (2009)

Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2016)

Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine
por: Cai, Hui, et al.
Publicado: (2018)

Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
por: Schiffner, Torben, et al.
Publicado: (2018)

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth
por: Wang, Xiaolei, et al.
Publicado: (2022)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2014)

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
por: Joshi, Shivali S., et al.
Publicado: (2020)

Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop
por: Qin, Yali, et al.
Publicado: (2015)

Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques
por: Amedee, Angela M, et al.
Publicado: (2004)

Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments
por: Hraber, Peter, et al.
Publicado: (2017)

Editorial: Integrative Computational Systems Biology Approaches in Immunology and Medicine
por: Kaderali, Lars, et al.
Publicado: (2019)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

Immunological and virological aspects of HIV cell-to-cell transfer
por: Schwartz, Olivier
Publicado: (2009)

Virology and Immunology Researchers Evolve with the Viruses We Study
por: Russell, Rodney S.
Publicado: (2020)

Insights into the virologic and immunologic features of SARS-COV-2
por: Polat, Ceylan, et al.
Publicado: (2021)

Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection
por: Andrieu, Jean-Marie, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_05iti5uj5r4j18pichckb7i5or